This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q25.1 | Special Copayment Reduction: V272 (rare disease) |
| B. Synonyms | Coarctation of the aorta | coarctation of the aorta (preductal, postductal) |
| C. Adult onset | Likelihood of first onset in adulthood: moderate — mild coarctation of the aorta is sometimes discovered in childhood~adulthood through upper-limb hypertension or incidentally. First diagnosis in adulthood is also possible in patients with Turner syndrome. Severe forms present with shock in the neonatal period. |
| 1. History | 1760 first described by Morgagni; 1944 first surgical resection·anastomosis by Crafoord·Nylin; 1982 percutaneous balloon angioplasty. |
| 2. Causes | Aortic narrowing adjacent to the ductus arteriosus; aortic media abnormality (abnormal contraction of ductal tissue); BAV associated in about 50~80%. |
| 3. Genetics | Multifactorial; NOTCH1, ELN associations reported; Turner syndrome (45,X) is the most important genetic association; family history of BAV. |
| 4. General epidemiology | About 1 in 3,500~4,000 births; about 5~8% of all CHD; male-to-female ratio about 1.5~2:1; 12~35% in Turner syndrome. |
| 5. Pathophysiology | Narrowing → upper-limb hypertension + lower-limb hypotension; development of collateral circulation; dual aortic pathology when BAV is associated. |
| 6. Symptoms | Neonates: shock (preductal type); children~adults: upper-limb hypertension, headache, lower-limb claudication, abnormal blood pressure response to exercise. |
| 7. Signs | Upper-lower limb blood pressure difference (upper > lower); radio-femoral pulse delay; systolic murmur at the left sternal border; rib notching (chest X-ray). |
| 8. Screening | Four-limb blood pressure measurement in the neonatal period; echocardiography in all with Turner syndrome; family (BAV-related) screening. |
| 9. Diagnosis | Echocardiography (Doppler pressure gradient, visualization of the narrowed segment); cardiac MRI/CT is the standard for precise anatomical assessment; direct pressure gradient measurement. |
| 10. Treatment | Surgical resection·end-to-end anastomosis or percutaneous balloon angioplasty/stent placement; PGE1 (neonatal crisis); follow-up for restenosis. |
| 11. Prognosis | Good survival after repair; lifelong follow-up needed for long-term complications (restenosis, aortic dissection, hypertension, BAV progression). |
| 12. Prevention | Early diagnosis (four-limb blood pressure, fetal echocardiography); Turner syndrome screening; blood pressure control after repair; aortic follow-up (dissection prevention). |
| 13. References | 10 major clinical guidelines and original papers |
Coarctation of the Aorta (CoA) is a relatively well-known congenital heart defect for which clinical research has accumulated over some 200 years since the Italian anatomist Giovanni Battista Morgagni first described it at autopsy in 1760. In 1903, Bonnet classified narrowing near the ductus arteriosus into preductal and postductal types, and this classification contributed to understanding clinical presentation and treatment strategy.
The history of surgical treatment began in 1944, when Clarence Crafoord and Gustaf Nylin of Sweden first succeeded with resection of an aortic coarctation and end-to-end anastomosis. In the same year, Gross and Hufnagel independently performed similar operations. Surgical techniques subsequently developed, and various methods were introduced, including end-to-end anastomosis, prosthetic graft interposition, and subclavian flap aortoplasty.
In 1982, Singer et al. first applied percutaneous balloon aortoplasty, and with the introduction of percutaneous stent placement in 1991, the role of interventional cardiology expanded. The high frequency of coarctation of the aorta in patients with Turner syndrome (45,X) is also an important clinical finding.
In Korea, surgical repair of coarctation of the aorta was standardized along with the development of pediatric cardiac surgery from the 1980s onward, and long-term follow-up is currently carried out under Special Copayment Reduction (V272) registration.
There are two main theories for the cause of coarctation of the aorta.
Hemodynamic theory: when fetal blood flow through the aortic isthmus is reduced, this region develops insufficiently and narrowing results. This theory explains why narrowing is more common when a ventricular septal defect (VSD) or bicuspid aortic valve (BAV) is present.
Ductal tissue theory: as smooth muscle cells within the ductus arteriosus contract during physiological closure, adjacent aortic tissue is pulled along, forming a narrowing. This theory explains well the anatomical fact that the narrowing is always located adjacent to the ductus (juxtaductal).
Associated bicuspid aortic valve (BAV): BAV is present in about 50~80% of patients with coarctation of the aorta. A shared developmental mechanism of BAV and coarctation (cardiac neural crest cell abnormality) is presumed.
Turner syndrome: in women with Turner syndrome with a 45,X karyotype, the frequency of coarctation of the aorta is very high, at about 12~35%. In Turner syndrome, congenital weakness of the aortic media underlies the aortic malformation.
Other associated anomalies: VSD, patent ductus arteriosus (PDA), mitral valve abnormalities, and subaortic stenosis are commonly associated.
The genetic basis of coarctation of the aorta is multifactorial and heterogeneous.
Turner syndrome (45,X): the most important genetic association, with a coarctation frequency of up to 12~35%. The effect of X-chromosome monosomy on aortic development is central. Women with Turner syndrome also have an increased risk of aortic dilation and aortic dissection.
NOTCH1 (9q34.3): NOTCH1 variants have been reported in some cases as a common genetic basis of BAV and coarctation. ELN (elastin gene) (7q11.23): in Williams syndrome, ELN deletion mainly causes supravalvular stenosis and pulmonary artery stenosis, but aortic abnormalities are also present in some.
Familial clustering: the frequency of congenital heart defects (especially BAV, coarctation) in first-degree relatives of patients with coarctation of the aorta is 4~10 times higher than in the general population. When there is a family history of BAV, echocardiographic family screening is recommended.
Clinically, chromosome analysis for Turner syndrome is performed in patients with coarctation of the aorta, and if BAV is associated, echocardiographic screening of first-degree relatives is recommended.
Coarctation of the aorta is a relatively common congenital heart defect occurring in about 1 in 3,500~4,000 births and accounts for about 5~8% of all congenital heart defects. It occurs more often in males, at a ratio of about 1.5~2:1.
It is broadly divided into the neonatal crisis form (severe narrowing + duct-dependent systemic circulation) and the form discovered in childhood~adulthood through upper-limb hypertension. The former requires immediate emergency care, whereas the latter may go undetected for decades.
Associated anomalies: BAV (50~80%), VSD (about 30%), patent ductus arteriosus (PDA, common in the neonatal form), mitral valve abnormalities, Shone complex.
In Turner syndrome (45,X), the frequency of coarctation is very high at 12~35%, so screening for coarctation of the aorta by echocardiography is mandatory in all women diagnosed with Turner syndrome.
In Korea, long-term follow-up management is provided in pediatric cardiology and adult congenital heart clinics under Special Copayment Reduction (V272) registration.
The core pathophysiology of coarctation of the aorta is the coexistence of proximal (above the narrowing) hypertension and distal (below the narrowing) hypotension, with the narrowed segment as the boundary.
Above the narrowing: upper-body hypertension develops, increasing the risk of cerebrovascular disease (stroke, intracranial aneurysm), left ventricular pressure overload (LVH), and coronary artery disease. Below the narrowing: lower-body hypoperfusion causes lower-limb claudication, renovascular hypertension (activation of the renin-angiotensin system), poor lower-limb growth, and similar problems. Collateral circulation: if the narrowing persists, collateral circulation develops via the internal mammary arteries, intercostal arteries, subclavian artery branches, and others to compensate for lower-body perfusion. Intercostal artery dilation appears on chest X-ray as rib notching, which is a diagnostic finding.
In severe neonatal narrowing, duct-dependent systemic circulation occurs, and shock develops when the ductus closes. In this case, maintaining ductal patency with PGE1 administration is essential.
When BAV is associated, aortic narrowing and aortic valve stenosis/regurgitation progress together, producing a complex hemodynamic load. Aortopathy is also more pronounced when BAV and coarctation coexist.
Neonatal period (severe preductal type): when the ductus closes, systemic circulation suddenly decreases, causing pallor, lethargy, metabolic acidosis, oliguria, and shock. Immediate stabilization with PGE1 administration is required.
Childhood~adulthood (mild~moderate): the most characteristic clinical finding is upper-limb hypertension + lower-limb hypotension (or unmeasurable blood pressure). An upper-lower limb systolic blood pressure difference >20 mmHg or radiofemoral pulse delay is the key diagnostic clue. Headache (due to hypertension), nosebleeds, and stiffness at the back of the neck are common. Lower-limb claudication (calf pain on exercise) may occur. Excessive upper-limb blood pressure rise and inadequate lower-limb blood pressure rise during exercise are characteristic.
Symptoms of complications: sudden headache·altered consciousness with rupture of an intracranial berry aneurysm. Sudden chest·back pain with aortic dissection.
Turner syndrome association: accompanied by systemic findings of Turner syndrome such as abnormal sexual development, short stature, and hearing abnormalities.
Blood pressure findings: upper-limb (right upper limb > left upper limb) hypertension and reduced or unmeasurable lower-limb blood pressure are characteristic. On simultaneous palpation of the radial and femoral pulses, radiofemoral pulse delay, in which the femoral pulse is felt later, is the classic sign of coarctation of the aorta. An upper-lower limb blood pressure difference of >20 mmHg is significant.
Auscultation findings: a systolic ejection murmur is heard at the upper left sternal border or between the scapulae. When BAV is associated, an aortic valve murmur is added. A continuous murmur through developed collateral circulation may be heard over the lateral chest.
Chest X-ray findings: ① rib notching: erosion of the inferior surfaces of the 3rd~8th ribs by dilated intercostal arteries (appears at age 8 or older). ② 3 sign: dilation above and below the aortic narrowing produces a shape resembling the number 3 on chest X-ray. ③ Dilation of the ascending aorta and cardiomegaly.
Electrocardiogram: findings of left ventricular hypertrophy. May be normal early on in children.
Four-limb blood pressure measurement: the most important clinical screening method for coarctation of the aorta. Upper-limb (both sides) and lower-limb (both sides) blood pressures are measured simultaneously or sequentially to confirm an upper-lower limb blood pressure difference (>20 mmHg) and reduced lower-limb blood pressure. Simultaneous palpation of the radial and femoral pulses is also important.
Echocardiographic screening in Turner syndrome: in all women diagnosed with Turner syndrome, echocardiography (and cardiac MRI if needed) is used to evaluate for coarctation of the aorta, BAV, and aortic dilation.
Family screening: echocardiographic screening is recommended for first-degree relatives of patients with BAV or coarctation of the aorta.
Neonatal SpO2 screening: pulse oximetry helps detect severe coarctation of the aorta (with cardiogenic shock, cyanosis).
Echocardiography: the standard for initial diagnosis. Through the suprasternal notch approach, an abnormal Doppler flow pattern at the narrowed segment (peak velocity >3 m/s, diastolic "piggyback" pattern) is confirmed. The location, morphology, and pressure gradient of the narrowing and any associated BAV and other anomalies are evaluated.
Cardiac MRI (CMR): precisely evaluates in three dimensions the overall aortic morphology (narrowed segment, length, collateral circulation, aortic arch anatomy) and hemodynamics (flow volume before and after the narrowing). It is the standard for planning and follow-up before surgery/intervention.
Cardiac CT angiography: used to evaluate the anatomy of the narrowed segment, collateral vessels, aneurysms, and stent position.
Cardiac catheterization: needed for direct measurement of the pressure gradient across the narrowing and when performing percutaneous balloon angioplasty·stent placement.
Neonatal emergency stabilization: in neonates with duct-dependent systemic circulation, ductal patency is maintained with PGE1 administration. Mechanical ventilation and inotropic support may be needed until repair.
Surgery: ① resection + end-to-end anastomosis: after resecting the narrowing, normal aorta is joined directly. The standard technique. ② Subclavian flap aortoplasty: widening of the narrowed segment using the left subclavian artery. ③ Prosthetic graft insertion (prosthetic patch or tube graft): used for complex anatomy or reoperation.
Percutaneous intervention: ① balloon aortoplasty: initial intervention in children or bridging therapy before surgical repair. There is a risk of restenosis. ② Endovascular stent: the preferred intervention in adults and adolescents. Restenosis rates are low and immediate hemodynamic improvement is excellent.
Blood pressure control: residual hypertension is common even after repair, so ACE inhibitors, β-blockers, and similar drugs are needed.
The prognosis of coarctation of the aorta is determined by the timing of repair and associated anomalies. Early repair (in childhood) favors long-term prognosis.
Short-term prognosis after repair: immediate hemodynamic improvement follows surgery or stent placement. Surgical mortality at specialized centers is 1~3% or less.
Long-term complications: ① restenosis: occurs in 5~10% of children after surgical repair and 5~15% of adults after stent placement. ② Persistent hypertension: hypertension persists in about 30~50% even after repair, and delayed repair (>14 years) is the most important prognostic factor. Persistent hypertension is a major cause of cardiovascular morbidity. ③ Aortic dissection: the risk of dissection increases with BAV-associated aortopathy. ④ Intracranial berry aneurysm: residual risk even after repair. ⑤ Infective endarteritis/endocarditis.
Overall, 30-year survival after repair is about 80~90%, but this is lower than in the general population, and the main causes of death are heart failure, stroke, and aortic complications.
Primary prevention of coarctation of the aorta is not possible. The key is to minimize long-term complications through early diagnosis and timely repair.
Early diagnosis: severe coarctation is detected early by four-limb blood pressure measurement and pulse oximetry in the neonatal period. Upper- and lower-limb blood pressure measurement is included in routine pediatric checkups.
Turner syndrome screening: immediately upon diagnosis of Turner syndrome, echocardiography is used to evaluate for coarctation, and even if normal, regular echocardiography·aortic MRI follow-up is performed into adulthood.
Blood pressure control after repair: residual hypertension is a major cause of cardiovascular complications, so aggressive blood pressure control (target <130/80 mmHg) is maintained. Lifelong cardiology follow-up is needed even after repair.
Aortic follow-up: in patients with associated BAV, aortic diameter is followed by cardiac MRI or CT every 1~3 years. Prophylactic surgery is considered if the aortic diameter is ≥50mm.
Prevention of infective endocarditis/endarteritis: prophylactic antibiotics before high-risk invasive procedures before and after repair.
Exercise restriction: high-intensity competitive sports are restricted in patients with unrepaired or residual narrowing (pressure gradient >20 mmHg).
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for adult congenital heart disease. Eur Heart J. 2021;42(6):563-645. PMID: 32860028.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for Adults with Congenital Heart Disease. J Am Coll Cardiol. 2008;52(23):e143-e263. PMID: 19038677.
Crafoord C, Nylin G. Congenital coarctation of the aorta and its surgical treatment. J Thorac Surg. 1945;14:347-361.
Rosenthal E. Coarctation of the aorta from fetus to adult: curable condition or life long disease process? Heart. 2005;91(11):1495-1502. DOI: 10.1136/hrt.2004.057182. PMID: 16230453.
Celermajer DS, Greaves K. Survivors of coarctation repair: fixed but not cured. Heart. 2002;88(2):113-114. DOI: 10.1136/heart.88.2.113. PMID: 12117826.
Canniffe C, Ou P, Walsh K, Bonnet D, Celermajer D. Hypertension after repair of aortic coarctation — a systematic review. Int J Cardiol. 2013;167(6):2456-2461. DOI: 10.1016/j.ijcard.2012.09.084. PMID: 23062580.
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900. PMID: 12084585.
Kaemmerer H, Fratz S, Bauer U, et al. Emergency hospital admissions and three-year survival of adults with and without cardiovascular surgery for congenital cardiac disease. J Thorac Cardiovasc Surg. 2003;126(4):1048-1052. PMID: 14566243.
Ou P, Bonnet D, Auriacombe L, et al. Late systemic hypertension and aortic arch geometry after successful repair of coarctation of the aorta. Eur Heart J. 2004;25(20):1853-1859. DOI: 10.1016/j.ehj.2004.08.022. PMID: 15474707.
Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998;101(1):E11. DOI: 10.1542/peds.101.1.e11. PMID: 9417175.